Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 17
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
4/26/2007
1.
Phase III Randomized Study of Autolymphocyte Therapy Using AL101 plus Cimetidine vs Cimetidine Alone in Patients with Renal Cell Carcinoma (Summary Last Modified 08/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
over 18
BUMC-MS-1
NCI-V88-0412
Last Modified:
12/1/1993
2.
Phase III Study of Adjuvant Autolymphocyte Therapy for T1-3 N1-3 M0 or T4 N0-3 M0 Renal Cell Carcinoma (Summary Last Modified 12/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
over 18
CUCCC-90-C01
NCI-V91-0009
Last Modified:
3/1/1994
3.
Phase III Randomized Double-Blind Placebo-Controlled Trial of Cimetidine in Patients with Gastric Cancer (Summary Last Modified 03/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
any age
CRC-TU-GA3004
EU-90033
Last Modified:
6/7/2004
4.
Phase II Study of Autologous Activated Lymphocytes plus Immunomodulation with High-Dose Cimetidine in Patients with Metastatic Cancer (Summary Last Modified 12/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Other
CBRG-9115
NBSG-9115, NCI-V93-0342
Last Modified:
3/19/2007
5.
Phase II Study of Interferon alfa and Interleukin-2 in Patients With Metastatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to physiologic 75
Other
CBRG-9510
NBSG-9510, NCI-V96-0835, NCT00002733
Last Modified:
12/6/2007
6.
Phase II Therapy with PALA/L-Alanosine and with Cimetidine as a Single Agent for Metastatic Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
NCCTG-837051
NCCTG-83-70-51
7.
Phase II Immunotherapy with Subcutaneous Alpha-2-Interferon in Patients with Multiple Myeloma, plus Cimetidine for Treatment Failures
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
YALE-HIC-3027
NCI-V84-0057
Last Modified:
10/1/1988
8.
Phase II Study of Autolymphocyte Therapy for the Treatment of Cancer for Which There is No Conventional Therapy Available (Summary Last Modified 10/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
BUMC-CT-2
NCI-V88-0411
9.
Phase II Autolymphocyte Therapy in Patients with Cancer for Which No Other Therapy Exists
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
BUMC-8603
NCI-V86-0041
Last Modified:
9/1/1988
10.
Phase II Randomized Study of Chemoimmunotherapy with IFL-RA/BCNU and BCNU/Cimetidine in Patients with Advanced Malignant Melanoma (Summary Last Modified 09/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NCCTG-857051
MAYO-857051, NCCTG-85-70-51
Select All on One Page
1
2
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute